ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Seagen Inc.
Mayo Clinic
Mayo Clinic
Kivu Bioscience Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
University of Chicago
Bayer
National Cancer Institute (NCI)
Convalife (Shanghai) Co., Ltd.
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Duke University
Rutgers, The State University of New Jersey
Arcus Biosciences, Inc.
Terremoto Biosciences Inc.
Kaiser Permanente
Sichuan Enray Pharmaceutical Sciences Company
Qurient Co., Ltd.
AstraZeneca